Authors
Loading...
Randomized trial examines CEO overconfidence effects on risk-taking in listed firms, suggesting implications for governance.
Onipe Adabenege Yahaya (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: